Abstract
BackgroundCG0070, is an Ad5-based oncolytic vaccine engineered to express GM-CSF and replicate selectively in tumor cells with mutated or deficient RB. The CG0070 mechanism of action includes cell lysis and...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have